Risk-Benefit Assessment of Opioids in Chronic Noncancer Pain
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 21 (4) , 283-296
- https://doi.org/10.2165/00002018-199921040-00004
Abstract
Opioids have been accepted as appropriate treatment for acute and cancer pain, but their role in the management of chronic nonmalignant pain is the subject of much debate, mainly due to concerns...Keywords
This publication has 64 references indexed in Scilit:
- Outcome of Chronic Opioid Therapy for Non-Cancer PainJournal of Pain and Symptom Management, 1998
- Practice guidelines for chronic pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Chronic Pain Section.1997
- Dihydrocodeine: A new opioid substrate for the polymorphic CYP2D6 in humans*Clinical Pharmacology & Therapeutics, 1995
- Current Issues in Cancer Palliative careBMJ, 1994
- Selection of analgesic therapies in rheumatoid arthritis the role of opioid medicationsArthritis & Rheumatism, 1993
- Paradoxical pain.BMJ, 1993
- Opioid Analgesics and the Risk of Hip Fracture in the Elderly: Codeine and PropoxypheneJournal of Gerontology, 1992
- Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of painPain, 1991
- Association of pain relief with drug side effects in postherpetic neuralgia: A single-dose study of clonidine, codeine, ibuprofen, and placeboClinical Pharmacology & Therapeutics, 1988
- Combination AnalgesicsThe American Journal of Medicine, 1984